TW200728406A - Dendritic polymers with enhanced amplification and interior functionality - Google Patents

Dendritic polymers with enhanced amplification and interior functionality

Info

Publication number
TW200728406A
TW200728406A TW095138387A TW95138387A TW200728406A TW 200728406 A TW200728406 A TW 200728406A TW 095138387 A TW095138387 A TW 095138387A TW 95138387 A TW95138387 A TW 95138387A TW 200728406 A TW200728406 A TW 200728406A
Authority
TW
Taiwan
Prior art keywords
dendritic
dendritic polymers
polymers
interior
reagents
Prior art date
Application number
TW095138387A
Other languages
Chinese (zh)
Other versions
TWI384032B (en
Inventor
Donald A Tomalia
Douglas R Swanson
Bao-Hua Huang
Veera Reddy Pulgam
Joseph R Heinzelmann
Sonke Svenson
Lori A Reyna
Michael A Zhuravel
Abhay Singh Chauhan
Cordell R Demattei
Original Assignee
Dendritic Nanotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/047635 external-priority patent/WO2006115547A2/en
Application filed by Dendritic Nanotechnologies Inc filed Critical Dendritic Nanotechnologies Inc
Publication of TW200728406A publication Critical patent/TW200728406A/en
Application granted granted Critical
Publication of TWI384032B publication Critical patent/TWI384032B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002—Dendritic macromolecules
    • C08G83/003—Dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595—Polyamides, e.g. nylon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/005—Reinforced macromolecular compounds with nanosized materials, e.g. nanoparticles, nanofibres, nanotubes, nanowires, nanorods or nanolayered materials
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00—Compositions of unspecified macromolecular compounds
    • C08L101/005—Dendritic macromolecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Manufacturing & Machinery (AREA)
  • Biochemistry (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)

Abstract

Dendritic polymers with enhanced amplification and interior functionality are disclosed. These dendritic polymers are made by use of fast, reactive ring-opening chemistry (or other fast reactions) combined with the use of branch cell reagents in a controlled way to rapidly and precisely build dendritic structures, generation by generation, with cleaner chemistry, often single products, lower excesses of reagents, lower levels of dilution, higher capacity method, more easily scaled to commercial dimensions, new ranges of materials, and lower cost. The dendritic compositions prepared have novel internal functionality, greater stability (e.g., thermal stability and less or no reverse Michael's reaction), and reach encapsulation surface densities at lower generations. Unexpectedly, these reactions of polyfunctional branch cell reagents with polyfunctional cores do not create cross-linked materials. Such dendritic polymers are useful as demulsifiers for oil/water emulsions, wet strength agents in the manufacture of paper, proton scavengers, polymers, nanoscale monomers, calibration standards for electron microscopy, making size selective membranes, and agents for modifying viscosity in aqueous formulations such as paint. When these dendritic polymers have a carried material associated with their surface and/or interior, then these dendritic polymers have additional properties for carrying materials due to the unique characteristics of the dendritic polymer, such as for drug delivery, transfection, and diagnostics.
TW095138387A 2005-12-21 2006-10-18 Dendritic polymers with enhanced amplification and interior functionality TWI384032B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/047635 WO2006115547A2 (en) 2005-04-20 2005-12-21 Dendritic polymers with enhanced amplification and interior functionality

Publications (2)

Publication Number Publication Date
TW200728406A true TW200728406A (en) 2007-08-01
TWI384032B TWI384032B (en) 2013-02-01

Family

ID=38375679

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095138387A TWI384032B (en) 2005-12-21 2006-10-18 Dendritic polymers with enhanced amplification and interior functionality

Country Status (2)

Country Link
KR (1) KR100954677B1 (en)
TW (1) TWI384032B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI401215B (en) * 2009-11-20 2013-07-11 Nat Univ Kaohsiung Separation and recovery of metal ions

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI524825B (en) 2012-10-29 2016-03-01 財團法人工業技術研究院 Method of transferring carbon conductive film
KR101722395B1 (en) 2014-09-23 2017-04-04 한국과학기술연구원 Mercapto-based polysilsesquioxane and method for preparing functional polysilsesquioxane using the same
KR20180026302A (en) * 2016-09-02 2018-03-12 장원범 Manufacturing method of electromagnetic waves shielding and absorption material, and electromagnetic waves shielding and absorption material thereby and sheet with the same
KR102498792B1 (en) * 2018-05-30 2023-02-13 주식회사 제우스 Method for detecting targent antigen and biological diagnosis device by using quantom-dot and quantom-dot bead comprising multifunctional ligand
US10954346B2 (en) 2018-12-27 2021-03-23 Industrial Technology Research Institute Resin and ink
CN115894942B (en) * 2022-11-07 2024-01-12 同济大学 Hyperbranched comb-type polylysine modified by polycaprolactone and application thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI401215B (en) * 2009-11-20 2013-07-11 Nat Univ Kaohsiung Separation and recovery of metal ions

Also Published As

Publication number Publication date
TWI384032B (en) 2013-02-01
KR20070066902A (en) 2007-06-27
KR100954677B1 (en) 2010-04-27

Similar Documents

Publication Publication Date Title
MX2007010402A (en) Dendritic polymers with enhanced amplification and interior functionality.
WO2006065266A3 (en) Dendritic polymers with enhanced amplification and interior functionality
TW200728406A (en) Dendritic polymers with enhanced amplification and interior functionality
Thakur et al. Synthesis and applications of biodegradable soy based graft copolymers: a review
Ago et al. High-throughput synthesis of lignin particles (∼ 30 nm to∼ 2 μm) via aerosol flow reactor: Size fractionation and utilization in pickering emulsions
Yamamoto et al. Topological polymer chemistry: a cyclic approach toward novel polymer properties and functions
Wu et al. POSS polymers: physical properties and biomaterials applications
Bentz et al. Hollow polymer nanocapsules: synthesis, properties, and applications
Zhao et al. ABC triblock copolymer vesicles with mesh-like morphology
Chen et al. Dual stimuli‐responsive supramolecular polypeptide‐based hydrogel and reverse micellar hydrogel mediated by host–guest chemistry
Salavagione et al. Recent advances in the covalent modification of graphene with polymers
Read et al. Recent advances in shell cross-linked micelles
Li et al. Self-assembly and applications of poly (glycidyl methacrylate) s and their derivatives
KR100943917B1 (en) Method for Preparation of Block Copolymeric Nanoparticles
Nam et al. Self-assembly of monolayer vesicles via backbone-shiftable synthesis of janus core–shell bottlebrush polymer
Kedzior et al. Incorporating cellulose nanocrystals into the core of polymer latex particles via polymer grafting
Allı et al. Poly (N-isopropylacrylamide) thermoresponsive cross-linked conjugates containing polymeric soybean oil and/or polypropylene glycol
ATE471758T1 (en) PARTICLE COMPOSITIONS AND THEIR PRODUCTION
Chen et al. Molecular bottlebrushes featuring brush-on-brush architecture
Yan et al. Insight into the polymerization-induced self-assembly via a realistic computer simulation strategy
Zuo et al. Engineering styrenic blends with poly (lactic acid)
Geurds et al. Tailored nanocellulose-grafted polymer brush applications
Hou et al. Surface nanostructures based on assemblies of polymer brushes
Lin et al. Scalable Preparation of Cylindrical Block Copolymer Micelles with a Liquid-Crystalline Perfluorinated Core by Photoinitiated Reversible Addition-Fragmentation Chain Transfer Dispersion Polymerization
Ye et al. Janus nanoshards prepared based on high internal phase emulsion templates for compatibilizing immiscible polymer blends

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees